Sale!

Preimplantation Genetic Disorder PGD HLA Typing Single Embryo

Original price was: $1,000.Current price is: $750.

-25%

Preimplantation Genetic Disorder PGD HLA Typing for single embryos is a sophisticated genetic screening procedure performed during in vitro fertilization (IVF) cycles. This specialized test identifies embryos free from specific inherited genetic disorders while simultaneously matching human leukocyte antigen (HLA) profiles to create potential stem cell donors for affected siblings. The test costs $750 USD and provides crucial information for families dealing with genetic conditions requiring bone marrow or stem cell transplantation. By analyzing trophectoderm cells through Sanger Sequencing, this procedure helps select healthy embryos that can serve as HLA-compatible donors for siblings with conditions like Fanconi anemia, thalassemia, or leukemia. The 3-week turnaround time allows for informed decision-making during the IVF process, offering hope to families facing complex genetic challenges.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

Preimplantation Genetic Disorder PGD HLA Typing Single Embryo

Comprehensive Genetic Screening for Family Health

Preimplantation Genetic Disorder PGD HLA Typing represents a groundbreaking advancement in reproductive medicine, combining genetic disorder screening with tissue matching capabilities. This sophisticated procedure is performed during in vitro fertilization (IVF) cycles to identify embryos free from specific inherited conditions while simultaneously matching their human leukocyte antigen (HLA) profiles to create potential stem cell donors for affected siblings.

What This Advanced Test Measures

Our Preimplantation Genetic Disorder PGD HLA Typing test provides comprehensive analysis through multiple detection methods:

  • Genetic Disorder Screening: Identifies embryos free from specific inherited conditions like Fanconi anemia, beta-thalassemia, or sickle cell disease
  • HLA Typing: Matches human leukocyte antigen profiles between embryos and affected siblings
  • Embryo Viability Assessment: Evaluates overall embryo health and development potential
  • Chromosomal Analysis: Screens for common chromosomal abnormalities that could affect implantation

Who Should Consider This Genetic Screening?

This specialized testing is particularly beneficial for families facing specific genetic challenges:

Primary Candidates Include:

  • Couples with children affected by inherited disorders requiring bone marrow transplantation
  • Families with history of Fanconi anemia, thalassemia, or other genetic conditions
  • Parents seeking HLA-matched sibling donors for children with leukemia or other blood disorders
  • Couples undergoing IVF who have known genetic disorders in their family history
  • Individuals with autosomal recessive or X-linked genetic conditions

Significant Benefits of PGD HLA Typing

Choosing Preimplantation Genetic Disorder PGD HLA Typing offers multiple advantages for family planning and medical treatment:

Medical and Family Benefits:

  • Disease Prevention: Significantly reduces the risk of passing inherited genetic disorders to future children
  • Treatment Opportunities: Creates potential stem cell donors for affected siblings requiring transplantation
  • Informed Decision-Making: Provides crucial genetic information before embryo transfer
  • Reduced Emotional Burden: Decreases anxiety about genetic disease transmission
  • Cost-Effective Solution: Potentially avoids lifelong medical expenses associated with genetic disorders

Understanding Your Test Results

Our comprehensive reporting provides clear, actionable information to guide your reproductive decisions:

Result Interpretation Guidelines:

  • HLA-Matched Embryos: Embryos that are both genetically healthy and HLA-compatible with affected siblings
  • Genetically Normal Embryos: Embryos free from the specific genetic disorder being screened
  • Carrier Status Embryos: Embryos that carry one copy of the genetic mutation but won’t develop the disease
  • Affected Embryos: Embryos that would develop the genetic disorder if transferred

Test Pricing and Availability

Test Component Price (USD)
Discount Price $750
Regular Price $1,000

Additional Test Information:

  • Turnaround Time: 3 weeks
  • Sample Type: Trophectoderm
  • Testing Method: Sanger Sequencing
  • Prescription Required: Doctor’s prescription needed (not applicable for surgery, pregnancy, or travel cases)

Nationwide Accessibility

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more cities. Our network of certified laboratories ensures consistent, high-quality results regardless of your location.

Take the Next Step Toward Family Health

Don’t let genetic concerns dictate your family’s future. Our Preimplantation Genetic Disorder PGD HLA Typing provides the scientific certainty and medical guidance needed for informed reproductive decisions. Contact our genetic counseling team today to discuss your specific situation and begin the testing process.

Call or WhatsApp our genetic specialists at +1(267) 388-9828 to schedule your consultation and learn how this advanced testing can benefit your family’s health journey.